Targeting the endocannabinoid system in the treatment of addiction disorders
Department of Psychology, Northcentral University, 2488 Historic Decatur Road San Diego, California, USA.
Review Article
GSC Biological and Pharmaceutical Sciences, 2022, 19(02), 064–074.
Article DOI: 10.30574/gscbps.2022.19.2.0175
Publication history:
Received on 05 April 2022; revised on 06 May 2022; accepted on 08 May 2022
Abstract:
This disquisition provides historical context illustrating the psychosocial, political, and bureaucratic barriers to applying a biomolecular approach to substance use disorders, focusing on what are arguably the most stigmatized molecules in America. It provides a biomolecular treatment strategy designed to mitigate multiple types of addiction by influencing the dopamine and serotonin neurotransmitters’ activity through phytocannabinoid supplementation of the endocannabinoid system and proposes a strategy for circumventing the bureaucratic obstacles.
Keywords:
Addiction; Cannabinoids; Dopamine; Serotonin; Nutraceutical; Biomolecular Psychology
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
